Data Challenges in Addressing Chronic Kidney Disease in Low- and Lower-Middle-Income Countries

Abstract

The burden of chronic kidney disease (CKD) is growing globally, particularly in low-and lower-middleincome countries (LLMICs) where access to treatment is poor and the largest increases in disease burden will occur. The individual and societal costs of kidney disease are well recognized, especially in developed health care systems where treatments for the advanced stages of CKD are more readily available. The consequences of CKD are potentially more catastrophic in developing health care systems where such resources are often lacking. Central to addressing this challenge is the availability of data to understand disease burden and ensure that investments in treatments and health resources are effective at a local level. Use of routinely collected administrative data is helpful in this regard, however, the barriers to developing a more systematic focus on data collection should not be underestimated. This article reviews the current tools that have been used to measure the burden of CKD and considers limitations regarding their use in LLMICs. A review of the literature investigating the use of registries, disease specific databases and administrative data to identify populations with CKD in LLMICs, which indicate these to be underused resources, is included. Suggestions regarding the potential use of administrative data for measuring CKD burden in LLMICs are explored.

Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019

“…Unexpectedly, sub-Saharan Africa with extremely poor life expectancies and little government health expenditure had the lowest ASIR from 1990 to 2019. The less advanced laboratory testing and unavailable data in many African countries might be responsible for the low “detected and reported” incident cases [ 21 , 22 ]. Therefore, it is important to raise the testing capacity and develop sustainable approaches to data measurement in these countries to discover the probably “masked” cases and develop more suitable prevention strategies in accordance with the real situation.…”

Artificial Intelligence in Kidney Disease: A Comprehensive Study and Directions for Future Research

“…Remarkably, nearly 95% of the published articles were authored by researchers from the top ten countries. Furthermore, a higher percentage of articles originated from developed nations (categorized by the World Bank) [32,33]. Notably, institutions in developed countries actively conducted research on the application of AI in the context of kidney disease [34].…”

Chronic kidney disease and the global public health agenda: an international consensus

“…Data registries are vital for understanding disease epidemiology, tracking progress and developing cost-effective intervention targets. Kidney disease registries are sparse in LICs and LMICs, which is where they are most needed 90 . A 2022 review of dialysis registries found none in large Asian countries 91 .…”